Showing results (751-760 of 773) with videos related to

Sort By:
Pageof 78
International Journal of Cancer|May 29, 2016
Integrated pathway analysis of nasopharyngeal carcinoma implicates the axonemal dynein complex in the Malaysian cohortYoon-Ming Chin, Lu Ping Tan, Norazlin Abdul Aziz, et al.
Scientific Reports|May 13, 2025
Reliability, validity and minimum clinical importance difference of the Chinese version of the Zurich claudication questionnaireYi-Xuan Gao, Zhi-Wen Weng, Hui Shao, et al.
Signal Transduction and Targeted Therapy|September 18, 2020
Novel insights into stress-induced susceptibility to influenza: corticosterone impacts interferon-β responses by Mfn2-mediated ubiquitin degradation of MAVSZhuo Luo, Li-Fang Liu, Ying-Nan Jiang, et al.
Scientific Reports|September 30, 2017
CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinomaSusan Ling Ling Hoe, Lu Ping Tan, Norazlin Abdul Aziz, et al.
World Journal of Gastrointestinal Surgery|August 9, 2023
Transcutaneous electrical acupoint stimulation in adult patients receiving gastrectomy/colorectal resection: A randomized controlled trialYuan-Tao Hou, Yuan-Yuan Pan, Lei Wan, et al.
Nature Communications|March 31, 2015
Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesisDazhi Xu, Chien-Feng Li, Xian Zhang, et al.
Oncogene|December 1, 2025
Targeted methylation of cg24067911 suppresses colorectal cancer metastasis through BCL6-ATXN1-CDH1 axisLu-Ping Yang, Jia-Qian Huang, Chiu-Wing Yeung, et al.
Developmental Biology|February 25, 2017
Histone H1 defect in escort cells triggers germline tumor in Drosophila ovaryZhihao Yang, Jin Sun, Yuzhao Hu, et al.
Journal of Advanced Research|August 15, 2025
Refining antibiotic cocktail regimens for pseudo-germ-free mice and their impact on gut microbiome and pancreatic tumor proteomicsSuraphan Panyod, Wei-Kai Wu, Yen-Peng Lee, et al.
The Lancet. Oncology|April 20, 2023
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 studyJianming Xu, Ken Kato, Eric Raymond, et al.
Pageof 78